Misoprostol for cervical preparation before IUCD insertion in patient with no previous vaginal birth

Tahani Ali Azeez 1, Huda Abbass Fadhil 2 and Moayad Aziz Alabdaly 3, *

1 Department of obstetrics and gynecology, College of Medicine, University of Nineveh, Iraq.
2 Department of community and family medicine, College of Medicine, University of Nineveh, Iraq.
3 Department of Anesthesia, Al Noor University College, Nineveh, Iraq.
 
Research Article
International Journal of Science and Research Archive, 2022, 06(02), 230–235.
Article DOI: 10.30574/ijsra.2022.6.2.0175
Publication history: 
Received on 21 July 2022; revised on 27 August 2022; accepted on 29 August 2022
 
Abstract: 
Background: Intrauterine devices (IUD) are extensively used as reversible contraceptives. Copper & Levonorgestrel releasing IUD (LNG (are safe, cost-effective over the long term, and just as effective in relation to others with tubal sterilization.
Aim of study: To investigate the effect of oral misoprostol on facilitating intrauterine device (IUD) placement in patients with a history of cesarean sections (Cs).
Method: It was a randomized clinical trial (RCT) study carried out on 98 women eligible for IUCD inclusion in the private outpatient clinic (obstetrics and gynecology) in search of contraception in the cities of Mosul and Erbil. This study ran from February 2020 to July 2021. All participants who requested an IUD had already had one or more cesarean sections and had never given birth vaginally. Participants were randomized into two equal groups; the first group was given misoprostol orally and the second group was given placebo 3 h before insertion of the IUD.
Result: In this clinical trial study, the mean age of the cases was (29 year) and for control group was (34.1year). The (ARR) is (0.2449), which reflects how much misoprostol lessens the risk of difficulties in IUD insertion. Women with cervical misoprostol preparation were found to have much higher abdominal cramps than those with placebo, with P value 0.0135. Inserting the IUD was a lot easier in the misoprostol group than in the placebo group, with P value of 0.0018 (<0.05) very significant. A higher incidence of complications like vaginal bleeding was also observed in the misoprostol group, with P value 0.0381 and the efficacy of the use misoprostol in the study group was (26%).
Conclusion: Our study found that a pill of misoprostol was administered orally before the insertion of an IUD in women who had not had a vaginal birth facilitated the insertion process
 
Keywords: 
Misoprostol; Intrauterine Device (IUD); Randomized clinical trial (RCT); Patient; Iraq
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0